Presenter: Leonard B. Weinstock, MD, FACG

Original Date: June 4, 2016

Low dose naltrexone (LDN) is a remarkable compound that increases endorphins which modulate inflammation and decreases pain by interacting with microglia. Many diseases and syndromes have been treated with LDN although there are few good studies in the literature. Published articles on 4 different diseases are discussed.

Includes a case presentation by Steven Sandberg-Lewis, ND, DHANP

0.5 Pharmacology and 0.25 General (Total 0.75 CEUs) approved by OBNM